A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond
利用 EXO-CD24 减轻 COVID-19 及其他疾病中免疫过度活跃的新型平台
期刊:EMBO Molecular Medicine
影响因子:9
doi:10.15252/emmm.202215997
Shiran Shapira, Marina Ben Shimon, Mori Hay-Levi, Gil Shenberg, Guy Choshen, Lian Bannon, Michael Tepper, Dina Kazanov, Jonathan Seni, Shahar Lev-Ari, Michael Peer, Dimitrios Boubas, Justin Stebbing, Sotirios Tsiodras, Nadir Arber
